|
|
.
See Category: Diseases of the musculoskeletal system and connective tissue
See Header: Dermatopolymyositis, unspecified
ICD-10 (CM) Code and Descriptor
|
M33.91 |
Dermatopolymyositis, unspecified with respiratory involvement
|
M3391 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 54.08%
|
20.32%
|
14.47%
|
4.59%
|
2.30%
|
1.61%
|
0.80%
|
0.46%
|
0.34%
|
0.57%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M33.91*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
96365
|
THER/PROPH/DIAG IV INF INIT |
165
|
165
|
|
96366
|
THER/PROPH/DIAG IV INF ADDON |
164
|
397
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
98
|
114
|
|
J1569
|
GAMMAGARD LIQUID INJECTION |
97
|
6,200
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
78
|
79
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
73
|
73
|
|
82550
|
ASSAY OF CK (CPK) |
58
|
58
|
|
80053
|
COMPREHEN METABOLIC PANEL |
57
|
57
|
|
J2930
|
METHYLPREDNISOLONE INJECTION |
57
|
57
|
|
J1566
|
IMMUNE GLOBULIN, POWDER |
51
|
2,540
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
42
|
86
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
41
|
41
|
|
J1459
|
INJ IVIG PRIVIGEN 500 MG |
40
|
2,040
|
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
40
|
48
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
39
|
116
|
|
85652
|
RBC SED RATE AUTOMATED |
39
|
39
|
|
96413
|
CHEMO IV INFUSION 1 HR |
39
|
39
|
|
J1568
|
OCTAGAM INJECTION |
39
|
1,730
|
|
86140
|
C-REACTIVE PROTEIN |
36
|
36
|
|
Q0163
|
DIPHENHYDRAMINE HCL 50MG |
35
|
35
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M33.91 related to the following DRG Codes:
545-547
|
